Cyclodextrin based erythropoietin formulation
    1.
    发明授权
    Cyclodextrin based erythropoietin formulation 失效
    基于环糊精的促红细胞生成素制剂

    公开(公告)号:US5376632A

    公开(公告)日:1994-12-27

    申请号:US906780

    申请日:1992-06-30

    摘要: The present invention relates to a new pharmaceutical composition for parenteral and local administration comprising an aqueous solution of erythropoietin and a .beta.- or .gamma.-cyclodextrin hydroxyalkyl derivative. The invention also relates to novel lyophilized or spray-dried erythropoietin compositions comprising a .beta.- or .gamma.-cyclodextrin hydroxyalkyl derivative, to processes for preparing such aqueous, lyophilized or spray-dried compositions and to a method for simultaneously stabilizing erythropoietin in an aqueous solution and preventing it from being adsorbed to surfaces.

    摘要翻译: 本发明涉及用于胃肠外和局部给药的新型药物组合物,其包含促红细胞生成素的水溶液和β-或γ-环糊精羟烷基衍生物。 本发明还涉及包含β-或γ-环糊精羟烷基衍生物的新型冻干或喷雾干燥的促红细胞生成素组合物,用于制备这种水性,冻干或喷雾干燥的组合物的方法以及在水溶液中同时稳定促红细胞生成素的方法, 防止其吸附在表面上。